| TARGET |
| Name | Advanced Medical Optics Inc (EYE) |
| Industries | Ophthalmic goods; Medical, dental, and hospital equipment & supplies |
| City | Santa Ana |
| State | CA |
| Nation | United States |
| Incorporated in | DE |
| Public Status | Public |
| Business Description | Advanced Medical Optics Inc, located in Santa Ana, California, manufactures and wholesales eyecare surgical equipment and products, with a focus on cataract surgery; Products in the cataract/implant line include intraocular lenses, phacoemulsification systems, viscoelastics, and related products used in cataract and refractive lenticular surgery. Products in the laser vision correction line include laser systems, wavefront diagnostic systems, microkeratomes and related products used in corneal refractive surgery. |
| Advisors | UBS Investment Bank; Goldman Sachs & Co |
| Target Sales | 1.20 billion U.S. Dollar |
|
| ACQUIROR |
| Name | Abbott Laboratories (ABT) |
| Industries | In vitro and in vivo diagnostic substances; Medicinal chemicals and botanical products; Biological products, except diagnostic substances; Laboratory analytical instruments; Surgical and medical instruments and apparatus; Electromedical and electrotherapeutic apparatus; Dry, condensed, and evaporated dairy products |
| City | Abbott Park |
| State | IL |
| Nation | United States |
| Incorporated in | IL |
| Public Status | Public |
| Business Description | Abbott Laboratories Inc, headquartered in Abbott Park, Illinois, manufactures and develops general pharmaceuticals and medical equipment. The company operates through its four divisions namely, Pharmaceutical Products, which offers adult and pediatric pharmaceuticals; Diagnostic Products, responsible for providing diagnostic systems and tests for blood banks, hospitals, commercial laboratories, physicians' offices, alternate-care testing sites, plasma protein therapeutic companies, and consumers; Nutritional Products, concerned with pediatrics and adult nutritional items; and Vascular Products, which provides a line of coronary, endovascular, and vessel closure devices for the treatment of vascular diseases. The company was founded in 1888. |
| Advisors | Morgan Stanley |
| Acquiror Sales | 28.80 billion U.S. Dollar |
|